Martin I. Freed - Jun 12, 2025 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by David Tyronne Howton as attorney-in-fact for Martin I Freed
Stock symbol
SLDB
Transactions as of
Jun 12, 2025
Transactions value $
$0
Form type
4
Date filed
6/13/2025, 04:27 PM
Previous filing
Jun 13, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Freed Martin I Director C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN /s/ by David Tyronne Howton as attorney-in-fact for Martin I Freed 2025-06-13 0001676653

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Director Stock Option (Right to Buy) Award $0 +77.5K $0.00 77.5K Jun 12, 2025 Common Stock 77.5K $4.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 12, 2025 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.